269 related articles for article (PubMed ID: 29694270)
1. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
Kaine J; Song X; Kim G; Hur P; Palmer JB
J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
[TBL] [Abstract][Full Text] [Related]
3. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
Feldman SR; Zhao Y; Shi L; Tran MH; Lu J
Arthritis Care Res (Hoboken); 2015 May; 67(5):708-17. PubMed ID: 25303478
[TBL] [Abstract][Full Text] [Related]
4. Incidence rates of comorbidities among patients with psoriasis in the United States.
Feldman SR; Hur P; Zhao Y; Tian H; Wei Z; Wang X; Herrera V
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677809
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Manag Care Spec Pharm; 2018 Jul; 24(7):654-663. PubMed ID: 29952710
[TBL] [Abstract][Full Text] [Related]
6. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
Skornicki M; Prince P; Suruki R; Lee E; Louder A
Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
[TBL] [Abstract][Full Text] [Related]
9. Direct healthcare costs and comorbidity burden among patients with psoriatic arthritis in the USA.
Merola JF; Herrera V; Palmer JB
Clin Rheumatol; 2018 Oct; 37(10):2751-2761. PubMed ID: 30051284
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
Radner H; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study.
Haque N; Lories RJ; de Vlam K
J Rheumatol; 2016 Feb; 43(2):376-82. PubMed ID: 26669922
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
[TBL] [Abstract][Full Text] [Related]
13. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
[No Abstract] [Full Text] [Related]
14. Comorbidities in Early Psoriatic Arthritis: Data From the Metabolic Disturbances in Psoriatic Arthritis Cohort Study.
Ishchenko A; Pazmino S; Neerinckx B; Lories R; de Vlam K
Arthritis Care Res (Hoboken); 2024 Feb; 76(2):231-240. PubMed ID: 37667975
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
[TBL] [Abstract][Full Text] [Related]
16. Health care utilization and costs associated with functional status in patients with psoriatic arthritis.
Ogdie A; Hwang M; Veeranki P; Portelli A; Sison S; Shafrin J; Pedro S; Hass S; Hur P; Kim N; Yi E; Michaud K
J Manag Care Spec Pharm; 2022 Sep; 28(9):997-1007. PubMed ID: 36001101
[No Abstract] [Full Text] [Related]
17. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population.
Lee S; Xie L; Wang Y; Vaidya N; Baser O
J Med Econ; 2018 Jun; 21(6):564-570. PubMed ID: 29359606
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database.
Feldman SR; Tian H; Gilloteau I; Mollon P; Shu M
BMC Health Serv Res; 2017 May; 17(1):337. PubMed ID: 28482887
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set.
Walsh JA; Song X; Kim G; Park Y
Clin Rheumatol; 2018 Jul; 37(7):1869-1878. PubMed ID: 29637483
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of cardiovascular risk factors in patients with psoriatic arthritis.
Khraishi M; Aslanov R; Rampakakis E; Pollock C; Sampalis JS
Clin Rheumatol; 2014; 33(10):1495-500. PubMed ID: 25034080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
